Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Dyne Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 83 | 2 | 93 | +12 |
| Shares | 35.3M | 330.2K | 47.8M | +12.9M (+36.8%) |
| Value | $572.8M | $5.36M | $568.3M | +$826.9K (+0.1%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Dyne Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106.2M | 9.76% |
| Deep Track Capital, LP | 2,292,250 | $27.3M | 2.01% |
| Assenagon Asset Management S.A. | 361,933 | $4.30M | 0.02% |
| Monashee Investment Management LLC | 95,300 | $1.13M | 0.28% |
| Tudor Investment Corp Et Al | 39,115 | $465.0K | 0.01% |
| Dimensional Fund Advisors LP | 36,012 | $428.0K | 0.00% |
| Summit Rock Advisors, LP | 34,887 | $415.0K | 0.25% |
| Martingale Asset Management L P | 31,814 | $379.0K | 0.00% |
| Jump Financial, LLC | 19,100 | $227.0K | 0.01% |
| HC Advisors, LLC | 18,784 | $223.0K | 0.14% |
| FMR LLC | 17,200 | $205.0K | 0.00% |
| ProShare Advisors LLC | 13,819 | $163.0K | 0.00% |
| Wells Fargo & Company | 12,045 | $144.0K | 0.00% |
| HSBC Holdings PLC | 11,005 | $130.0K | 0.00% |
| Daiwa Securities Group Inc. | 150 | $2.00K | 0.00% |
| Washington Trust Advisors, Inc. | 63 | $1.00K | 0.00% |
| Toronto Dominion Bank | 3 | $0 | 0.00% |
Sold out (5)
Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| SG Americas Securities, LLC | 71,317 | $1.16M |
| Penn Mutual Asset Management, LLC | 34,886 | $567.0K |
| Point72 Hong Kong Ltd | 2,308 | $37.0K |
| Signaturefd, LLC | 49 | $1.00K |
| Harbour Investments, Inc. | 9 | $0 |
Not filed for Q4 2021 yet (2)
Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 327,227 | $5.31M |
| First Mercantile Trust Co | 3,007 | $49.0K |